Outcomes of Descemet-Stripping Endothelial Keratoplasty in 52 Eyes With Iridocorneal Endothelial Syndrome

• Published in: Cornea Vol. 41; no. 2; p. 159
• Main Authors: Mohamed, Ashik, Chaurasia, Sunita, Senthil, Sirisha, Choudhari, Nikhil S
• Format: Journal Article
• Language: English
• Published: United States 01.02.2022
• Subjects: Adult; Aged; Descemet Stripping Endothelial Keratoplasty - methods; Female; Follow-Up Studies; Graft Rejection - epidemiology; Graft Survival; Humans; Incidence; India - epidemiology; Iridocorneal Endothelial Syndrome - diagnosis; Iridocorneal Endothelial Syndrome - surgery; Male; Middle Aged; Retrospective Studies; Time Factors; Visual Acuity; India
• ISSN: 1536-4798
• DOI: 10.1097/ICO.0000000000002699

To evaluate the long-term outcomes of Descemet-stripping endothelial keratoplasty (DSEK) in 52 eyes with iridocorneal endothelial (ICE) syndrome. Retrospective study of 52 eyes of 52 patients who were diagnosed with ICE syndrome and underwent DSEK between January 2010 and December 2019 with a follow-up of at least 6 months. The mean age was 48.8 ± 10.8 years. Female patients (n = 33) constituted 63.5%. The median duration of follow-up was 2.4 years (range, 0.5-9.1 yrs). The mean best-corrected visual acuity improved significantly after surgery and remained stable (∼20/50) through 5 years. The mean endothelial cell loss was 28%, 37.9%, 43.6%, and 56.9% at 6 months and at 1, 2, and 3 years, respectively. Graft rejection was noted in 5 eyes (9.6%). Postoperatively, increased intraocular pressure (IOP) was seen in 17 eyes (32.7%), and 10 eyes (19.2%) underwent glaucoma surgeries. Fourteen eyes (26.9%) had secondary graft failures. The estimates of graft success were 93.6% ± 3.6% at 1 year, 85.6% ± 5.5% at 2 years, 79.3% ± 6.7% at 3 years, 69.0% ± 8.9% at 4 years, and 59.1% ± 11.9% at 5 years. Postoperative increased IOP was found to be the only significant (P = 0.05) risk factor (hazard ratio 8.92) associated with graft failure. The clinical variant of ICE syndrome did not seem to influence the graft survival (P = 0.68). In this study, DSEK had a success rate of ∼60% at 5 years. Increased IOP post-DSEK is a significant risk factor for graft failure. Graft survival is not affected by the clinical variant of ICE syndrome.